Evofem Biosciences' : Proxy for 14 September 2023 Annual Meeting of Stockholders -Today at 10:18 pm
The first and only FDA-approved, on demand, hormone-free contraceptive vaginal gel. Our expenses were reduced by 42% in a post-COVID environment, which enabled us to dramatically reduce our net loss,...